Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 Sep;66(3):511–516. doi: 10.1172/JCI109882

Evidence for a Role of Free Fatty Acids in the Regulation of Somatostatin Secretion in Normal and Alloxan Diabetic Dogs

Taro Wasada 1,2, Barbara Howard 1,2, Richard E Dobbs 1,2, Roger H Unger 1,2
PMCID: PMC371679  PMID: 6105166

Abstract

To investigate the effect of acute elevation of plasma free fatty acids (FFA) on the secretion of splanchnic somatostatin-like immunoreactivity (SLI), the peripheral venous, pancreatic, and gastric venous effluent levels of SLI were measured in normal and chronic alloxan diabetic dogs before and after the infusion of a fat emulsion supplemented with heparin. In normal conscious dogs heparin injected during the infusion of a fat emulsion elevated FFA levels from a mean (±SE) base-line level of 0.7±0.1 meq/liter to a peak value of 1.5±0.1 meq/liter (P < 0.001) and plasma SLI rose from a mean (±SE) base-line value of 145±7 pg/ml to a peak of 253±44 pg/ml (P < 0.05). Neither the infusion of glycerol, of fat emulsion without heparin, of heparin alone nor of saline itself had an effect on either the plasma level of FFA or SLI. In another group of anesthetized dogs with surgically implanted catheters the administration of fat emulsion plus heparin was accompanied by more than a two-fold rise in the concentration of SLI in the venous effluent of the pancreas and of the gastric fundus and antrum in association with an elevation of FFA levels. In a group of conscious diabetic dogs fat emulsion plus heparin raised FFA from a mean base-line level of 1.2±0.2 to 1.6±0.3 meq/liter (P < 0.05) and SLI rose from a mean base-line level of 185±9 pg/ml to a peak value of 310±44 pg/ml (P < 0.01). Although SLI levels were significantly greater than in normal dogs at several time points after the rise in FFA, the magnitude of the increment in diabetic dogs did not differ from normal. These results demonstrate that a rise in FFA levels is a potent stimulus for SLI secretion from the pancreas and stomach and raise the possibility that FFA is an important physiological regulator of SLI secretion.

Full text

PDF
511

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti K. G., Christensen N. J., Christensen S. E., Hansen A. P., Iversen J., Lundbaek K., Seyer-Hansen K., Orskov H. Inhibition of insulin secretion by somatostatin. Lancet. 1973 Dec 8;2(7841):1299–1301. doi: 10.1016/s0140-6736(73)92873-0. [DOI] [PubMed] [Google Scholar]
  2. Arimura A., Sato H., Coy D. H., Schally A. V. Radioimmunoassay for GH-release inhibiting hormone. Proc Soc Exp Biol Med. 1975 Mar;148(3):784–789. doi: 10.3181/00379727-148-38631. [DOI] [PubMed] [Google Scholar]
  3. Barden N., Alvarado-Urbina G., Côté J. P., Dupont A. Cyclic AMP-dependent stimulation of somatostatin secretion by isolated rat islets of Langerhans. Biochem Biophys Res Commun. 1976 Aug 9;71(3):840–844. doi: 10.1016/0006-291x(76)90907-4. [DOI] [PubMed] [Google Scholar]
  4. Bloom S. R., Ralphs D. N., Besser G. M., Hall R., Coy D. H., Kastin A. J., Schally A. V. Proceedings: Effect of somatostatin on motilin levels and gastric emptying. Gut. 1975 Oct;16(10):834–834. [PubMed] [Google Scholar]
  5. Bloom W. L. Blood vessel binding of free fatty acid and venous thrombosis. Metabolism. 1967 Sep;16(9):777–786. doi: 10.1016/0026-0495(67)90180-1. [DOI] [PubMed] [Google Scholar]
  6. Boden G., Sivitz M. C., Owen O. E., Essa-Koumar N., Landor J. H. Somatostatin suppresses secretin and pancreatic exocrine secretion. Science. 1975 Oct 10;190(4210):163–165. doi: 10.1126/science.1166308. [DOI] [PubMed] [Google Scholar]
  7. Brennan M. F., Fitzpatrick G. F., Cohen K. H., Moore F. D. Glycerol: major contributor to the short term protein sparing effect of fat emulsions in normal man. Ann Surg. 1975 Oct;182(4):386–394. doi: 10.1097/00000658-197510000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Conlon J. M., Srikant C. B., Ipp E., Schusdziarra V., Vale W., Unger R. H. Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma. J Clin Invest. 1978 Dec;62(6):1187–1193. doi: 10.1172/JCI109238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Crespin S. R., Greenough W. B., 3rd, Steinberg D. Stimulation of insulin secretion by infusion of free fatty acids. J Clin Invest. 1969 Oct;48(10):1934–1943. doi: 10.1172/JCI106160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Edwards J. C., Howell S. L., Taylor K. W. Fatty acids as regulators of glucagon secretion. Nature. 1969 Nov 22;224(5221):808–809. doi: 10.1038/224808a0. [DOI] [PubMed] [Google Scholar]
  11. Efendic S., Luft R., Grill V. Effect of somatostatin on glucose induced insulin release in isolated perfused rat pancreas and isolated rat pancreatic islets. FEBS Lett. 1974 Jun 1;42(2):169–172. doi: 10.1016/0014-5793(74)80778-7. [DOI] [PubMed] [Google Scholar]
  12. GOODMAN D. S. The interaction of human erythrocytes with sodium palmitate. J Clin Invest. 1958 Dec;37(12):1729–1735. doi: 10.1172/JCI103765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gerich J. E., Langlois M., Schneider V., Karam J. H., Noacco C. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man. J Clin Invest. 1974 May;53(5):1284–1289. doi: 10.1172/JCI107675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gustavsson S., Lundqvist G. Inhibition of pancreatic somatostatin release in response to glucose. Biochem Biophys Res Commun. 1978 Jun 29;82(4):1229–1235. doi: 10.1016/0006-291x(78)90319-4. [DOI] [PubMed] [Google Scholar]
  15. HOAK J. C., POOLE J. C., ROBINSON D. S. THROMBOSIS ASSOCIATED WITH MOBILIZATION OF FATTY ACIDS. Am J Pathol. 1963 Dec;43:987–998. [PMC free article] [PubMed] [Google Scholar]
  16. Harris V., Conlon J. M., Srikant C. B., McCorkle K., Schusdziarra V., Ipp E., Unger R. H. Measurements of somatostatin-like immunoreactivity in plasma. Clin Chim Acta. 1978 Jul 15;87(2):275–283. doi: 10.1016/0009-8981(78)90348-0. [DOI] [PubMed] [Google Scholar]
  17. Hawley H. P., Gordon G. B. The effects of long chain free fatty acids on human neutrophil function and structure. Lab Invest. 1976 Feb;34(2):216–222. [PubMed] [Google Scholar]
  18. Henderson A. H., Most A. S., Parmley W. W., Gorlin R., Sonnenblick E. H. Depression of myocardial contractility in rats by free fatty acids during hypoxia. Circ Res. 1970 Apr;26(4):439–449. doi: 10.1161/01.res.26.4.439. [DOI] [PubMed] [Google Scholar]
  19. Howard B. V., Savage P. J., Nagulesparan M., Bennion L. J., Unger R. H., Bennett P. H. Evidence for marked sensitivity to the antilipolytic action of insulin in obese maturity-onset diabetics. Metabolism. 1979 Jul;28(7):744–750. doi: 10.1016/0026-0495(79)90180-x. [DOI] [PubMed] [Google Scholar]
  20. Ipp E., Dobbs R. E., Arimura A., Vale W., Harris V., Unger R. H. Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest. 1977 Sep;60(3):760–765. doi: 10.1172/JCI108829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jaspan J., Polonsky K., Lewis M., Moossa A. R. Reduction in portal vein blood flow by somatostatin. Diabetes. 1979 Oct;28(10):888–892. doi: 10.2337/diab.28.10.888. [DOI] [PubMed] [Google Scholar]
  22. Kimura T., Toung J. K., Margolis S., Bell W. R., Cameron J. L. Respiratory failure in acute pancreatitis: the role of free fatty acids. Surgery. 1980 May;87(5):509–513. [PubMed] [Google Scholar]
  23. Koerker D. J., Ruch W., Chideckel E., Palmer J., Goodner C. J., Ensinck J., Gale C. C. Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science. 1974 Apr 26;184(4135):482–484. doi: 10.1126/science.184.4135.482. [DOI] [PubMed] [Google Scholar]
  24. Kronheim S., Berelowitz M., Pimstone B. L. A radioimmunoassay for growth hormone release-inhibiting hormone: method and quantitative tissue distribution. Clin Endocrinol (Oxf) 1976 Nov;5(6):619–630. doi: 10.1111/j.1365-2265.1976.tb03865.x. [DOI] [PubMed] [Google Scholar]
  25. Luyckx A. S., Lefebvre P. J. Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc Soc Exp Biol Med. 1970 Feb;133(2):524–528. doi: 10.3181/00379727-133-34511. [DOI] [PubMed] [Google Scholar]
  26. Madison L. L., Seyffert W. A., Jr, Unger R. H., Barker B. Effect on plasma free fatty acids on plasma glucagon and serum insulin concentrations. Metabolism. 1968 Apr;17(4):301–304. doi: 10.1016/0026-0495(68)90097-8. [DOI] [PubMed] [Google Scholar]
  27. Malaisse W. J., Malaisse-Lagae F. Stimulation of insulin secretion by noncarbohydrate metabolites. J Lab Clin Med. 1968 Sep;72(3):438–448. [PubMed] [Google Scholar]
  28. Mortimer C. H., Tunbridge W. M., Carr D., Yeomans L., Lind T., Coy D. H., Bloom S. R., Kastin A., Mallinson C. N., Besser G. M. Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet. 1974 Apr 20;1(7860):697–701. doi: 10.1016/s0140-6736(74)92903-1. [DOI] [PubMed] [Google Scholar]
  29. Oliver M. F., Kurien V. A., Greenwood T. W. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet. 1968 Apr 6;1(7545):710–714. doi: 10.1016/s0140-6736(68)92163-6. [DOI] [PubMed] [Google Scholar]
  30. Raptis S., Schlegel W., Lehmann E., Dollinger H. C., Zoupas C. Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism. 1978 Sep;27(9 Suppl 1):1321–1328. doi: 10.1016/0026-0495(78)90066-5. [DOI] [PubMed] [Google Scholar]
  31. Schauder P., McIntosh C., Arends J., Arnold R., Frerichs H., Creutzfeldt W. Somatostatin and insulin release from isolated rat pancreatic islets in response to D-glucose, l-leucine, alpha-ketoisocaproic acid or D-glyceraldehyde: evidence for a regulatory role of adenosine-3' ,5'-cyclic monophosphate. Biochem Biophys Res Commun. 1977 Apr 11;75(3):630–635. doi: 10.1016/0006-291x(77)91519-4. [DOI] [PubMed] [Google Scholar]
  32. Schusdziarra V., Harris V., Arimura A., Unger R. H. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients. Endocrinology. 1979 Jun;104(6):1705–1708. doi: 10.1210/endo-104-6-1705. [DOI] [PubMed] [Google Scholar]
  33. Schusdziarra V., Harris V., Conlon J. M., Arimura A., Unger R. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest. 1978 Sep;62(3):509–518. doi: 10.1172/JCI109154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schusdziarra V., Rouiller D., Harris V., Conlon J. M., Unger R. H. The response of plasma somatostatin-like immunoreactivity to nutrients in normal and alloxan diabetic dogs. Endocrinology. 1978 Dec;103(6):2264–2273. doi: 10.1210/endo-103-6-2264. [DOI] [PubMed] [Google Scholar]
  35. Schusdziarra V., Rouiller D., Pietri A., Harris V., Zyznar E., Conlon J. M., Unger R. H. Pancreatic and gastric release of somatostatinlike immunoreactivity during intestinal phase of a meal. Am J Physiol. 1979 Dec;237(6):E555–E560. doi: 10.1152/ajpendo.1979.237.6.E555. [DOI] [PubMed] [Google Scholar]
  36. Schusdziarra V., Zyznar E., Rouiller D., Boden G., Brown J. C., Arimura A., Unger R. H. Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science. 1980 Feb 1;207(4430):530–532. doi: 10.1126/science.7352262. [DOI] [PubMed] [Google Scholar]
  37. Seyffert W. A., Jr, Madison L. L. Physiologic effects of metabolic fuels on carbohydrate metabolism. I. Acute effect of elevation of plasma free fatty acids on hepatic glucose output, peripheral glucose utilization, serum insulin, and plasma glucagon levels. Diabetes. 1967 Nov;16(11):765–776. doi: 10.2337/diab.16.11.765. [DOI] [PubMed] [Google Scholar]
  38. Soloni F. G., Sardina L. C. Colorimetric microdetermination of free fatty acids. Clin Chem. 1973 Apr;19(4):419–424. [PubMed] [Google Scholar]
  39. Weir G. C., Samols E., Day J. A., Jr, Patel Y. C. Glucose and glucagon stimulate the secretion of somatostatin from the perfused canine pancreas. Metabolism. 1978 Sep;27(9 Suppl 1):1223–1226. doi: 10.1016/0026-0495(78)90047-1. [DOI] [PubMed] [Google Scholar]
  40. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES